Though elevated SEMA7A is observed in breast cancer, where we have established a role for it in conferring cell survival, in part, via promotion of anoikis resistance [21, 24], the role of SEMA7A in normal MECs has not previously been investigated. This evidence concerns the gene SEMA7A and breast carcinoma.